BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36980726)

  • 1. Cellular Therapies in Chronic Lymphocytic Leukemia and Richter's Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell Transplant.
    Coombs CC; Easaw S; Grover NS; O'Brien SM
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular Therapy Advances in Chronic Lymphocytic Leukemia and Richter's Syndrome.
    Bajwa A; Voorhees TJ; Kittai AS
    Curr Probl Cancer; 2022 Feb; 46(1):100827. PubMed ID: 34991902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Richter's Transformation.
    Sigmund AM; Kittai AS
    Curr Oncol Rep; 2022 Aug; 24(8):1081-1090. PubMed ID: 35384590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
    Levy Yurkovski I; Tadmor T
    Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantation.
    Kutsch N; Gödel P; Voltin CA; Hallek M; Scheid C; Borchmann P; Holtick U
    Eur J Haematol; 2024 Jun; 112(6):984-987. PubMed ID: 38316549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
    Brudno JN; Somerville RP; Shi V; Rose JJ; Halverson DC; Fowler DH; Gea-Banacloche JC; Pavletic SZ; Hickstein DD; Lu TL; Feldman SA; Iwamoto AT; Kurlander R; Maric I; Goy A; Hansen BG; Wilder JS; Blacklock-Schuver B; Hakim FT; Rosenberg SA; Gress RE; Kochenderfer JN
    J Clin Oncol; 2016 Apr; 34(10):1112-21. PubMed ID: 26811520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Richter's transformation in chronic lymphocytic leukemia.
    Jain P; O'Brien S
    Oncology (Williston Park); 2012 Dec; 26(12):1146-52. PubMed ID: 23413591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
    Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
    Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL.
    Tzankov A; Fong D
    Med Hypotheses; 2006; 66(3):577-9. PubMed ID: 16223567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
    Liu E; Marin D; Banerjee P; Macapinlac HA; Thompson P; Basar R; Nassif Kerbauy L; Overman B; Thall P; Kaplan M; Nandivada V; Kaur I; Nunez Cortes A; Cao K; Daher M; Hosing C; Cohen EN; Kebriaei P; Mehta R; Neelapu S; Nieto Y; Wang M; Wierda W; Keating M; Champlin R; Shpall EJ; Rezvani K
    N Engl J Med; 2020 Feb; 382(6):545-553. PubMed ID: 32023374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation.
    Lahoud OB; Devlin SM; Maloy MA; Roeker LE; Dahi PB; Ponce DM; Gyurkocza B; Koehne G; Young JW; Castro-Malaspina HR; Barker JN; Papadopoulos EB; Jakubowski AA; Zelenetz AD; Mato AR; Giralt SA; Perales MA; Sauter CS
    Blood Adv; 2021 Jul; 5(14):2879-2889. PubMed ID: 34297048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT.
    Bruzzi JF; Macapinlac H; Tsimberidou AM; Truong MT; Keating MJ; Marom EM; Munden RF
    J Nucl Med; 2006 Aug; 47(8):1267-73. PubMed ID: 16883004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-chronic lymphocytic leukemia showed triple transformation, to diffuse large B cell, CD20-negative, and T-cell neoplasm during ofatumumab treatment: a case report.
    Imataki O; Uemura M
    BMC Clin Pathol; 2018; 18():5. PubMed ID: 29796007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
    Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
    BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Richter's Syndrome with Hypercalcemia Induced by Tumor-Associated Production of Parathyroid Hormone-Related Peptide.
    Watanabe N; Yasuda H; Morishita S; Aota Y; Tomomatsu J; Tanaka M; Ohsaka A; Komatsu N
    Case Rep Oncol; 2017; 10(1):123-126. PubMed ID: 28203174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
    Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
    Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Richter's Transformation with Novel Therapies.
    Bajwa A; Habib A; Kittai AS
    Curr Hematol Malig Rep; 2024 Apr; 19(2):45-55. PubMed ID: 38194201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies.
    Borogovac A; Siddiqi T
    Semin Hematol; 2024 Jan; ():. PubMed ID: 38290860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia.
    Bair SM; Porter DL
    Am J Hematol; 2019 May; 94(S1):S10-S17. PubMed ID: 30861173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia.
    Kovalovsky D; Yoon JH; Cyr MG; Simon S; Voynova E; Rader C; Wiestner A; Alejo J; Pittaluga S; Gress RE
    Leukemia; 2021 Sep; 35(9):2581-2591. PubMed ID: 33633313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.